Page 16 - தொழிற்சங்கம் ஆரோக்கியம் அமைச்சர் கடுமையான News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Covid vaccine: WHO emergency Covid-19 vaccine listing aims to lift access in poor countries, Health News, ET HealthWorld
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Covid vaccine: Singapore starts Covid-19 vaccination exercise, Health News, ET HealthWorld
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Updated Dec 29, 2020 | 21:19 IST
Vardhan will be representing the South East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board. Union Health Minister Harsh Vardhan. | File photo 
New Delhi: Union Health Minister Dr Harsh Vardhan has been nominated by the Global Alliance for Vaccines and Immunisation (GAVI) as a member on the GAVI Board, according to the Ministry of Health and Family Welfare.
Vardhan will be representing the South East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board. The seat is currently held by Myint Htwe of Myanmar.
Vardhan will be representing India from January 1, 2021 until December 31, 2023.
India s first fully indigenous pneumococcal vaccine launched
IANS
Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, on Monday announced the launch of India s first indigenously developed pneumococcalvaccine Pneumosil in the presence of Union Health Minister Harsh Vardhan.
Pneumosil has been developed through collaboration spanning over a decade among the Serum Institute, PATH and the Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.
The vaccine will provide effective and long-lasting protection for children against pneumococcal diseases. The vaccine makes the Serum Institute the world s third supplier of pneumococcal conjugate vaccines (PCV) under the pneumococcal Advance Market Commitment (AMC), and the first developing country vaccine manufacturer to access the global PCV
India launches first fully indigenous pneumococcal vaccine Filed on December 28, 2020
Alamy
Serum Institute is also testing and producing the Oxford-AstraZeneca Covid-19 vaccine in India
Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, on Monday announced the launch of India s first indigenously developed pneumococcal vaccine - Pneumosil - in the presence of Union Health Minister Harsh Vardhan.
Pneumosil has been developed through collaboration spanning over a decade among the Serum Institute, PATH and the Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.
vimarsana © 2020. All Rights Reserved.